[PDF] Top 20 Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction
Has 10000 "Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction" found on our website. Below are the top 20 most common "Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction".
Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction
... types of DES without differentiating between SES and ...stent in myocardial infarction with ST-segment elevation; STRATEGY, Single High Dose Bolus Tirofiban and ... Voir le document complet
13
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction
... comparing drug-eluting stents with bare-metal stents in patients undergoing primary PCI of ST-segment elevation acute ... Voir le document complet
8
Resolute zotarolimus‐eluting stent in ST‐elevation myocardial infarction (resolute‐STEMI): A prespecified prospective register from the DAPT‐STEMI trial
... Revascularisation of the acutely occluded vessel by means of primary percutaneous coronary intervention (pPCI) has evolved as the gold stan- dard treatment for patients presenting with ... Voir le document complet
5
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients
... assessed in hospital, at 1, 6, and 9 months, 1 and 2 ...unaware of the patients’ treatment assignments adjudicated all ...composite of MACE, defined as cardiac death, myocardial ... Voir le document complet
8
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
... 2013 of the Pubmed, Embase, Cochrane database, the Current Controlled Trials Register and KoreaMed, IndMed and LILACS by using search terms that included “bone marrow cells, “stem cell”, “precursor cell”, ... Voir le document complet
24
Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French “real-world” prospective GARO Registry
... stimuli of neointimal thickening like localized hypersensitivity, non-uniform drug deposition, polymers and drug resistance 20,21 ...treatment of DES-ISR remains highly ...analysis of ... Voir le document complet
31
Meeting Report : ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007
... process with adequate concealment of allo- cation and blind adjudication of clinical endpoints is needed to avoid bias in the interpretation of data, but this can only be achieved ... Voir le document complet
10
Patients with myocardial infarction and normal coronary arteriogram.
... transmural in 1 1 cases. The mean follow-up was 21.6 months. Eleven patients developed residual chest pain at rest early after myocardial infarction. One, treated.. by beta-blockers, suf[r] ... Voir le document complet
8
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis
... 2013 of the Pubmed, Embase, Cochrane database, the Current Con- trolled Trials Register and KoreaMed, IndMed and LILACS by using search terms that included ‘‘bone marrow cells’,“ “stem cell’’, ‘‘precursor cell’’, ... Voir le document complet
10
Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study
... Predic- tive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation my[r] ... Voir le document complet
12
Influence of functional deficiency of complement mannose-binding lectin on outcome of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
... part of the general population and sup- ports the view that I/R injury leads to significant inflammatory tissue damage that limits the benefits achieved by the reperfusion ...egies in I/R injury should have ... Voir le document complet
7
Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarction according to use of reperfusion therapy: Data from the FAST-MI program 1995-2015
... Twenty-year trends in profile, management and outcomes of patients with ST-segment elevation myocardial infarc- tion according to use of reperfusion therapy: Data from the FAST-MI progra[r] ... Voir le document complet
11
Impact of diabetes mellitus on long-term outcome after unstable angina and non-ST-segment elevation myocardial infarction treated with a very early invasive strategy
... secutive patients admitted to our centre with UA/NSTEMI were treated with a very early invasive ...strategy. Patients were eligible for inclusion in this study if they underwent ... Voir le document complet
8
How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction?
... restoration of myocardial perfusion is the main aim in the treatment of STEMI patients and coronary stenting is regarded as optimal therapy for most ...invasively in STEMI, ... Voir le document complet
13
Reduction of ST-elevation myocardial infarction in Canton Ticino (Switzerland) after smoking bans in enclosed public places—No Smoke Pub Study
... reduction in the incidence of STEMI admissions among the overall population of CT after the enforcement of a smoking ban in public ...reduction in the incidence of STEMI ... Voir le document complet
5
Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents
... Conflict of interest: none ...compared with tissue plasminogen activator in acute myocardial infarc- ...Arteries in Patients with Acute Myocardial Infarction ... Voir le document complet
7
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry.
... Coronary Stents in Octogenarians A 1-Year Analysis of the Worldwide e-SELECT Registry Young Joon Hong, MD,* Myung Ho Jeong, MD,* Alexander Abizaid, MD,† Adrian Banning, MD,‡ Antonio Bartorelli, MD,§ ... Voir le document complet
10
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials
... treatment with an ACE-inhibitor and a beta-blocker) in all symptomatic HFrEF patients and after a MI with an LVEF≤40% or diabetes 24-26 ...effect of MRA on top of standard ...all ... Voir le document complet
30
Oversizing and Restenosis with Self-Expanding Stents in Iliofemoral Arteries
... Statistical Analysis Continuous variables are expressed as mean ± standard deviation or median with ranges as appropriate. Intergroup comparisons were performed by two-tailed Student’s t test or Mann–Whitney test ... Voir le document complet
8
Impact of medical practice guidelines on the assessment of patients with acute coronary syndrome without persistent ST segment elevation
... time of the initial ...availability of risk classification for immediate use at the ...allocating patients to specific treatment and ...delay in reaching the appropriate diagnosis and starting ... Voir le document complet
8
Sujets connexes